LungPoint system results presented at American Thoracic Society 2010 International Conference

MAY 17, 2010, NEW ORLEANS, LA — Broncus Technologies, Inc., a medical device company focused on developing minimally-invasive innovations for lung diseases, announced today at the American Thoracic Society 2010 International Conference the availability of its LungPoint system version 2.1. The bronchoscopic navigation system is featured in three poster presentations at the meeting.

ATS publishes joint statement on renal failure in the ICU patient

Despite the fact that recent medical advances have allowed healthcare professionals to stabilize patients who would have otherwise died, many stabilized patients later develop organ system failure. In fact, acute renal failure is one of the biggest threats to critically ill patients: forty percent of patients with this condition die.

New TB booster shows promise

A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.

The study has been published online ahead of print publication in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Possible vaccine for mesothelioma proven safe

Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient’s own dendritic cells (DC) with antigen from the patient’s tumor, was able to induce a T-cell response against mesothelioma tumors.